HOME >> MEDICINE >> NEWS
HIV-1 protease inhibitors: Effective against malaria?

Protease inhibitors used to treat HIV-1 infection may also be effective for treatment or prevention of malaria, according to a study published in the December 15 issue of The Journal of Infectious Diseases, now available online. The study found protease inhibitors inhibited the growth of P. falciparum, the malaria parasite that causes most disease. These findings may also expose a previously unexplored vulnerability in the parasite that could lead to a new class of anti-malarial drug. While the effects of such drugs on co-infection need to be investigated, the study's findings may be especially significant in sub-Saharan Africa and other areas of the developing world where there are high rates of HIV and malaria co-infection.

Scientists from the Queensland Institute of Medical Research tested the effects of the protease inhibitors saquinavir, ritonavir, nelfinavir, amprenavir, and indinavir, as well as the non-nucleoside reverse transcriptase inhibitor nevirapine, on a drug-resistant line of P. falciparum. Saquinavir, ritonavir, and indinavir all inhibited parasite growth in vitro at levels routinely achieved in human patients, with saquinavir and ritonavir showing the most potent effect on the parasite. Saquinavir was most effective in the study and was equally effective on chloroquine-sensitive and -resistant parasite lines, while nelfinavir and amprenavir did not demonstrate anti-malarial activity. The research builds on a previous study that demonstrated antiretroviral agents can reduce the adhesion of P. falciparum-infected erythrocytes to endothelial surfaces.

The authors believe that the antiretroviral protease inhibitors attack the malaria parasite in ways that current antimalarial treatments do not. While the mode of antimalarial action of the drugs was not uncovered in the study, the authors hypothesize that the antiretrovirals inhibit an aspartyl protease, which helps the parasite digest hemoglobin and is located on the food vacuole of the
'"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
8-Nov-2004


Page: 1 2

Related medicine news :

1. HIV-1 spread through six transmission lines in the UK
2. Virco establishes comprehensive set of clinical cutoffs for the vircoTYPE HIV-1 resistance test
3. Supervised treatment interruptions fail to control HIV-1 viremia
4. Potential low-cost options for monitoring HIV-1-infected children in less-developed countries
5. Substantial survival increase after highly active antiretroviral therapy for HIV-1 infection
6. Antiretrovirals reduce mother-to-child HIV-1 transmission when started after childbirth
7. Pet scans could provide insight into HIV-1 progression
8. Further evidence for effectiveness of nevirapine in reducing mother-to-child HIV-1 transmission
9. Spermicide gel could increase risk of HIV-1 infection
10. Timely antiretroviral therapy essential for best prognosis in people with HIV-1 infection
11. Reduction in HIV-1 incidence among rural Ugandans gives hope to other African countries

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: HIV protease inhibitors Effective against malaria

(Date:5/23/2013)... (PRWEB) May 23, 2013 Sika ... and waterproofing membranes, today announced Imperial Roof Systems of ... for professionalism and dedication to quality during the re-roofing ... Roof Systems is a Sika Sarnafil Elite contractor and ... “Imperial Roof Systems is committed to sustainable building practices ...
(Date:5/23/2013)... To kick off barbecue season, fire up the grill ... calories with simple tips from Retrofit weight loss . ... summer. , “The powerful heat of the grill can be ... are not mindful of your selections, it can be as ... Amy Margulies. , Margulies advises clients to choose healthy options ...
(Date:5/23/2013)... 2013 Diabetes is one of the ... a nuisance when patients are unfortunate enough to become ... National Diabetes Information Clearinghouse at http://goo.gl/QyhCz , about ... of developing neuropathy which further shrivels the nervous system ... patients. Such nerve damage affects the whole body instead ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 A medical ... Media Surge, LLC. Targeting members of the medical and ... and attract new patients, the consulting service is focused ... strategies. , The medical Internet marketing agency is providing ... get results online. As part of the consulting, the ...
(Date:5/23/2013)... 2013 Professional Insurance Plans, an independent ... to celebrate Fibromyalgia Education and Awareness Month. As a ... the country, the agency feels that it is important ... syndrome that affects an estimated 10 million of Americans. ... the definition of Fibromyalgia (FM) is, “a common and ...
Breaking Medicine News(10 mins):Health News:Sika Sarnafil Announces Recycling Project of the Year Winner 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 3Health News:Neuropathy Nerve Damage Can Now Be Reversed With Neuracel 2Health News:Healthcare Internet Marketing Consulting Services Launched by JD Media Surge 2Health News:Professional Insurance Plans Encourages the Nation to Celebrate Fibromyalgia Education and Awareness Month 2
(Date:5/23/2013)... 23, 2013  PAREXEL International Corporation (NASDAQ: ... at the Jefferies Healthcare Conference in New York.  ... Chief Financial Officer, will be making a presentation on ... Monday, June 3, 2013. A live webcast ... section of PAREXEL,s website at www.PAREXEL.com in ...
(Date:5/22/2013)... , May 22, 2013  Aribex, Inc., manufacturer of ... today introduced a new color option, black with gray ... dental and veterinary markets. The popular white with light ... will continue to be available and both models can ... (Photo: http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental ...
(Date:5/22/2013)... NEW YORK , May 22, 2013 /PRNewswire/ ... is investigating potential claims on behalf of purchasers ... or the "Company") (NasdaqGS: AMAG -News).  The investigation ... violated federal securities laws. On May ... 10.73% during intraday trading after the company announced ...
Breaking Medicine Technology:PAREXEL International To Present At Jefferies Healthcare Conference 2Aribex Unveils New Color of NOMAD Pro 2 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2
Cached News: